CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 221 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $82 | -99.9% | 3,645 | -3.3% | 0.00% | 0.0% |
| Q3 2022 | $84,000 | 0.0% | 3,770 | +1.7% | 0.00% | -33.3% |
| Q2 2022 | $84,000 | -23.6% | 3,706 | -25.6% | 0.00% | +200.0% |
| Q1 2022 | $110,000 | +307.4% | 4,984 | +297.8% | 0.00% | 0.0% |
| Q4 2021 | $27,000 | +8.0% | 1,253 | +8.7% | 0.00% | 0.0% |
| Q3 2021 | $25,000 | +525.0% | 1,153 | +639.1% | 0.00% | – |
| Q2 2021 | $4,000 | – | 156 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $4,000 | -66.7% | 275 | -68.6% | 0.00% | – |
| Q3 2018 | $12,000 | +140.0% | 876 | +172.0% | 0.00% | – |
| Q2 2018 | $5,000 | – | 322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,340,193 | $227,229 | 10.94% |
| Novo Holdings A/S | 3,377,768 | $92,044,178 | 6.80% |
| Parallel Advisors, LLC | 3,723,483 | $101,446,294 | 3.38% |
| TANAKA CAPITAL MANAGEMENT INC | 37,569 | $1,024 | 2.92% |
| S&T BANK/PA | 334,252 | $9,107 | 1.76% |
| Birchview Capital, LP | 50,000 | $1,362,250 | 1.16% |
| Granite Investment Partners, LLC | 798,552 | $21,756,549 | 0.91% |
| FAS Wealth Partners, Inc. | 310,764 | $8,466,766 | 0.90% |
| Clearview Wealth Advisors LLC | 25,258 | $688,155 | 0.85% |
| Bridge City Capital, LLC | 43,485 | $1,184,749 | 0.60% |